Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases

Daniele Focosi; Sara Galimberti; Mario Petrini

doi:10.3324/haematol.11981

References

Yoosufani Z, Slavin JJ, Hellman R, Sethi S, Spencer R. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma. J Nucl Med. 1987; 28:1348-50. PubMed Google Scholar

Brown A, Greening W, McGready V. Radioiodine treatment of metastatic thyroid carcinoma; the Royal Marsden Hospital experience. Br J Radial. 1984; 57:323-7. Google Scholar

Thomson J. Acute leukemia following administration of radioiodine for thyrotoxicosis. Lancet. 1963; 186:978-9. https://doi.org/10.1016/S0140-6736(01)58525-6 Google Scholar

Vetter H, Hofer R. Acute leukaemia following radioiodine therapy of thyrotoxicosis. Br J Radiol. 1959; 32:263-4. PubMed https://doi.org/10.1259/0007-1285-32-376-263 Google Scholar

Ghadban W, Zirie M, Al-Khateeb DJAA, Mobayedh H, El-Aloosy A. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication. Saudi Med J. 2003; 24:347-51. PubMed Google Scholar

Read CJ, Tansey M, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab. 2004; 89:4229-33. PubMed https://doi.org/10.1210/jc.2003-031223 Google Scholar

Laurenti L, Salutari P, Sica S. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders. Ann Hematol. 1998; 76:271-2. PubMed https://doi.org/10.1007/s002770050400 Google Scholar

Blom P, Querido A, Leeksma C. Acute leukaemia following x-ray and radioiodine treatment of thyroid carcinoma. Br J Radiol. 1955; 28:165-6. PubMed https://doi.org/10.1259/0007-1285-28-327-165 Google Scholar

Roldan Schilling V, Fernandez Abellan P, Dominguez Escribano J, Rivas Gonzalez C, Mut Barbera E, Calatayud Cendra R. Acute leukemias after treatment with radioiodine for thyroid cancer. Haematologica. 1998; 83:767-8. PubMed Google Scholar

Hall P, Boice J, Berg G. Leukaemia after iodine-131 exposure. Lancet. 1992; 340:1-4. PubMed Google Scholar

Advani S, Hege U. Acta Oncol. 1992; 31:65. PubMed Google Scholar

Brincker H, Hansen H, Anderson A. Induction of leukemia by I-131 treatment of thyroid carcinoma. Br J Cancer. 1973; 28:232-7. PubMed https://doi.org/10.1038/bjc.1973.142 Google Scholar

Pochin E. Prospects for the treatment of thyroid carcinoma with radioiodide. Clin Radial. 1967; 18:113-5. https://doi.org/10.1016/S0009-9260(67)80001-1 Google Scholar

Hall P, Holm L. Cancer in iodine-131 exposed patients. J Endocrinol Invest. 1992; 18:147-9. Google Scholar

Bitton R, Sachmechi I, Benegalrao Y, Schneider B. Leukemia after a small dose of radioiodine for metastatic thyroid cancer. J Clin Endocrinol Metab. 1993; 77:1423-6. PubMed https://doi.org/10.1210/jc.77.5.1423 Google Scholar

Kolade V, Bosinski T, Ruffy E. Acute promyelocytic leukemia after iodine-131 therapy for Graves' disease. Pharmacotherapy. 2005; 25:1017-20. PubMed https://doi.org/10.1592/phco.2005.25.7.1017 Google Scholar

Shimon I, Kneller A, Olchovsky D. Clin Endocrinol (Oxf). 1995; 43:651-4. PubMed Google Scholar

Wang K, Lin L, Chen P, Lin H. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma. J Chin Med Assoc. 2005; 68:230-3. PubMed Google Scholar

Pavithran K, Doval D. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine. Am J Clin Oncol. 2005; 28:216. PubMed https://doi.org/10.1097/01.coc.0000143845.79889.33 Google Scholar

Walgraeve D, Verhoef G, Stul M. Cancer Genet Cytogenet. 1991; 55:217-24. PubMed https://doi.org/10.1016/0165-4608(91)90080-E Google Scholar

De Vathaire F, Schlumberger M, Delisle M. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer. 1997; 75:734-9. Google Scholar

Hoffman D, McConahey W, Fraumeni J, Kurland L. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol. 1982; 11:218-24. PubMed https://doi.org/10.1038/bjc.1997.130 Google Scholar

Holm L, Hall P, Wiklund K. Cancer risk after iodine-131 therapy for hyperthyroidism. 1995; 86:1026-7. PubMed https://doi.org/10.1093/ije/11.3.218 Google Scholar

Edmonds C, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol. 1986; 59:45-51. Google Scholar

Wiseman J, Hales I, Joasoo A. Two cases of lymphoma of the parotid gland following ablative radioiodine therapy for thyroid carcinoma. Clin Endocrinol (Oxf). 1982; 17:85-9. PubMed https://doi.org/10.1259/0007-1285-59-697-45 Google Scholar

Hackshaw A, Harmer CMU, Haq M, Franklyn J. J Clin Endocrinol Metab. 2007; 92:28-38. PubMed Google Scholar

Article Information

Vol. 92 No. 9 (2007): September, 2007 : Online Only Articles

DOI

https://doi.org/10.3324/haematol.11981

Published

2007-09-01

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

[bib1] Yoosufani Z, Slavin JJ, Hellman R, Sethi S, Spencer R. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma. J Nucl Med. 1987; 28:1348-50. PubMed Google Scholar

[bib2] Brown A, Greening W, McGready V. Radioiodine treatment of metastatic thyroid carcinoma; the Royal Marsden Hospital experience. Br J Radial. 1984; 57:323-7. Google Scholar

[bib3] Thomson J. Acute leukemia following administration of radioiodine for thyrotoxicosis. Lancet. 1963; 186:978-9. https://doi.org/10.1016/S0140-6736(01)58525-6 Google Scholar

[bib4] Vetter H, Hofer R. Acute leukaemia following radioiodine therapy of thyrotoxicosis. Br J Radiol. 1959; 32:263-4. PubMed https://doi.org/10.1259/0007-1285-32-376-263 Google Scholar

[bib5] Ghadban W, Zirie M, Al-Khateeb DJAA, Mobayedh H, El-Aloosy A. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication. Saudi Med J. 2003; 24:347-51. PubMed Google Scholar

[bib6] Read CJ, Tansey M, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab. 2004; 89:4229-33. PubMed https://doi.org/10.1210/jc.2003-031223 Google Scholar

[bib7] Laurenti L, Salutari P, Sica S. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders. Ann Hematol. 1998; 76:271-2. PubMed https://doi.org/10.1007/s002770050400 Google Scholar

[bib8] Blom P, Querido A, Leeksma C. Acute leukaemia following x-ray and radioiodine treatment of thyroid carcinoma. Br J Radiol. 1955; 28:165-6. PubMed https://doi.org/10.1259/0007-1285-28-327-165 Google Scholar

[bib9] Roldan Schilling V, Fernandez Abellan P, Dominguez Escribano J, Rivas Gonzalez C, Mut Barbera E, Calatayud Cendra R. Acute leukemias after treatment with radioiodine for thyroid cancer. Haematologica. 1998; 83:767-8. PubMed Google Scholar

[bib10] Hall P, Boice J, Berg G. Leukaemia after iodine-131 exposure. Lancet. 1992; 340:1-4. PubMed Google Scholar

[bib11] Advani S, Hege U. Acta Oncol. 1992; 31:65. PubMed Google Scholar

[bib12] Brincker H, Hansen H, Anderson A. Induction of leukemia by I-131 treatment of thyroid carcinoma. Br J Cancer. 1973; 28:232-7. PubMed https://doi.org/10.1038/bjc.1973.142 Google Scholar

[bib13] Pochin E. Prospects for the treatment of thyroid carcinoma with radioiodide. Clin Radial. 1967; 18:113-5. https://doi.org/10.1016/S0009-9260(67)80001-1 Google Scholar

[bib14] Hall P, Holm L. Cancer in iodine-131 exposed patients. J Endocrinol Invest. 1992; 18:147-9. Google Scholar

[bib15] Bitton R, Sachmechi I, Benegalrao Y, Schneider B. Leukemia after a small dose of radioiodine for metastatic thyroid cancer. J Clin Endocrinol Metab. 1993; 77:1423-6. PubMed https://doi.org/10.1210/jc.77.5.1423 Google Scholar

[bib16] Kolade V, Bosinski T, Ruffy E. Acute promyelocytic leukemia after iodine-131 therapy for Graves' disease. Pharmacotherapy. 2005; 25:1017-20. PubMed https://doi.org/10.1592/phco.2005.25.7.1017 Google Scholar

[bib17] Shimon I, Kneller A, Olchovsky D. Clin Endocrinol (Oxf). 1995; 43:651-4. PubMed Google Scholar

[bib18] Wang K, Lin L, Chen P, Lin H. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma. J Chin Med Assoc. 2005; 68:230-3. PubMed Google Scholar

[bib19] Pavithran K, Doval D. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine. Am J Clin Oncol. 2005; 28:216. PubMed https://doi.org/10.1097/01.coc.0000143845.79889.33 Google Scholar

[bib20] Walgraeve D, Verhoef G, Stul M. Cancer Genet Cytogenet. 1991; 55:217-24. PubMed https://doi.org/10.1016/0165-4608(91)90080-E Google Scholar

[bib22] De Vathaire F, Schlumberger M, Delisle M. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer. 1997; 75:734-9. Google Scholar

[bib23] Hoffman D, McConahey W, Fraumeni J, Kurland L. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol. 1982; 11:218-24. PubMed https://doi.org/10.1038/bjc.1997.130 Google Scholar

[bib24] Holm L, Hall P, Wiklund K. Cancer risk after iodine-131 therapy for hyperthyroidism. 1995; 86:1026-7. PubMed https://doi.org/10.1093/ije/11.3.218 Google Scholar

[bib25] Edmonds C, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol. 1986; 59:45-51. Google Scholar

[bib26] Wiseman J, Hales I, Joasoo A. Two cases of lymphoma of the parotid gland following ablative radioiodine therapy for thyroid carcinoma. Clin Endocrinol (Oxf). 1982; 17:85-9. PubMed https://doi.org/10.1259/0007-1285-59-697-45 Google Scholar

[bib27] Hackshaw A, Harmer CMU, Haq M, Franklyn J. J Clin Endocrinol Metab. 2007; 92:28-38. PubMed Google Scholar

Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases

References

Figures & Tables

Article Information

Article Usage

Statistics from Altmetric.com

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More